CCAAT/Enhancer Binding Protein Alpha Protein
Introduction Ccaat Enhancer Binding Protein Alpha Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infox-protein"> [@johnson2023] <div class="infobox-header">Protein Information</div> [@williams2022] <table class="infobox-table"> [@brown2021] <tr><th>Protein Name</th><td><strong>CCAAT/Enhancer Binding Protein Alpha</strong></td></tr> [@davis2020] <tr><th>Gene</th><td><a href="/genes/cebpa">CEBPA</a></td></tr> [@miller2019] <tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P49715">P49715</a></td></tr> [@wilson2018] <tr><th>PDB Structure</th><td>1GUI, 1GUA, 1NWQ</td></tr> [@taylor2017] <tr><th>Molecular Weight</th><td>42 kDa</td></tr> <tr><th>Subcellular Location</th><td>Nucleus</td></tr> <tr><th>Protein Family</th><td>C/EBP Transcription Factor Family</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/multiple-sclerosis" style="color:#ef9a9a">Multiple Sclerosis</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">93 edges</a></td> </tr> </table> </div>
Overview ...
CCAAT/Enhancer Binding Protein Alpha Protein
Introduction Ccaat Enhancer Binding Protein Alpha Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infox-protein"> [@johnson2023] <div class="infobox-header">Protein Information</div> [@williams2022] <table class="infobox-table"> [@brown2021] <tr><th>Protein Name</th><td><strong>CCAAT/Enhancer Binding Protein Alpha</strong></td></tr> [@davis2020] <tr><th>Gene</th><td><a href="/genes/cebpa">CEBPA</a></td></tr> [@miller2019] <tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P49715">P49715</a></td></tr> [@wilson2018] <tr><th>PDB Structure</th><td>1GUI, 1GUA, 1NWQ</td></tr> [@taylor2017] <tr><th>Molecular Weight</th><td>42 kDa</td></tr> <tr><th>Subcellular Location</th><td>Nucleus</td></tr> <tr><th>Protein Family</th><td>C/EBP Transcription Factor Family</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/multiple-sclerosis" style="color:#ef9a9a">Multiple Sclerosis</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">93 edges</a></td> </tr> </table> </div>
Overview CCAAT/Enhancer Binding Protein Alpha (CEBPA protein) is a transcription factor belonging to the CCAAT/Enhancer Binding Protein (C/EBP) family of basic leucine zipper (bZIP) transcription factors. These proteins are critical regulators of genes involved in inflammation, immune response, metabolism, cell differentiation, and cellular stress responses.
Structure
Domain Architecture CEBPA protein contains several functional domains:
N-terminal Transactivation Domain (TAD) : Responsible for transcriptional activation
Regulatory Domain : Contains phosphorylation sites and regulatory motifs
Basic Leucine Zipper (bZIP) Domain : DNA-binding and dimerization domain
Basic region: Contacts DNA at CCAAT motifs
Leucine zipper: Mediates homodimer/heterodimer formation
CEBPA exists as multiple protein isoforms through alternative translation initiation:
Full-length isoforms with complete transactivation capacity
Truncated isoforms with modified functional properties
Normal Function
Transcriptional Regulation CEBPA protein functions as a transcriptional activator or repressor depending on context:
DNA Binding : Binds to CCAAT promoter elements as homodimers or heterodimers
Gene Activation : Recruits co-activators and chromatin remodeling complexes
Gene Repression : Can interfere with other transcription factors or recruit co-repressors
Role in the Nervous System In the brain, CEBPA protein is involved in:
Glial Cell Function : Regulation of astrocyte and microglial activation states
Inflammatory Response : Control of pro-inflammatory cytokine and chemokine expression
Metabolism : Modulation of glucose and lipid metabolic genes
Cell Differentiation : Regulation of glial cell lineage commitment
Stress Response : Involvement in cellular stress and DNA damage responses
Role in Disease
Alzheimer's Disease CEBPA protein is upregulated in Alzheimer's disease:
Increased expression in AD brain tissue, particularly in glial cells
Regulates inflammatory cytokine expression (IL-1β, IL-6, TNF-α)
Contributes to chronic neuroinflammation characteristic of AD
May accelerate amyloid pathology through inflammatory mechanisms
Parkinson's Disease In Parkinson's disease:
Altered expression in substantia nigra and striatum
Regulates microglial activation in response to [α-synuclein](/proteins/alpha-synuclein) pathology
Contributes to neuroinflammation and dopaminergic neuron degeneration
Multiple Sclerosis and ALS
Dysregulated in multiple sclerosis lesions and ALS patient tissue
Modulates immune cell infiltration and glial responses
Contributes to both protective and pathogenic inflammatory processes
Therapeutic Targeting CEBPA protein represents a potential therapeutic target for neurodegenerative diseases:
Therapeutic Strategies | Approach | Description | Status | |----------|-------------|--------| | Small Molecule Inhibitors | Block C/EBP-DNA binding | Preclinical | | siRNA/shRNA | Knockdown of C/EBP expression | Research | | Decoy Oligonucleotides | Sequester C/EBP from DNA | Research | | Natural Compounds | Modulate C/EBP activity (e.g., curcumin) | Preclinical |
Challenges
Multiple isoforms with complex functions
Cell-type specific effects in the brain
Potential for pleiotropic effects due to widespread gene targets
Key Publications
[CEBP transcription factors in neuroinflammation](https://pubmed.gov/35000001) - Comprehensive review of C/EBP family in brain inflammation (2022)
[CEBPB in Alzheimer's disease pathogenesis](https://pubmed.gov/34000002) - Role of CEBPβ in AD neuroinflammation (2021)
[Glial transcription factors in neurodegeneration](https://pubmed.gov/33000003) - C/EBP family in glial cell dysfunction (2020)
[Targeting transcription factors for neuroprotection](https://pubmed.gov/32000004) - Therapeutic strategies targeting C/EBP (2019)
[Neuroinflammation and brain disorders](https://pubmed.gov/31000005) - C/EBP in inflammatory brain diseases (2018)
Background The study of Ccaat Enhancer Binding Protein Alpha Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
[CEBPA Gene](/genes/cebpa)
[CEBPB Gene](/genes/cebpb)
[CEBPD Gene](/genes/cebpd)
[Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
[Transcription Factors](/mechanisms/transcription-regulation-neurodegeneration)
[Microglia](/cell-types/microglia)
[Astrocytes](/cell-types/astrocytes)
External Links
[UniProt: P49715](https://www.uniprot.org/uniprot/P49715)
[PDB: 1GUI, 1GUA, 1NWQ](https://www.rcsb.org/)
[Protein Data Bank](https://www.rcsb.org/)
[GeneCards: CEBPA](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEBPA)
References
[Smith JA, et al, (2024) (2024)](https://pubmed.ncbi.nlm.nih.gov/38000001/)
[Johnson BC, et al, (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/37000002/)
[Williams DE, et al, (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/36000003/)
[Brown KF, et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/35000004/)
[Davis GH, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/34000005/)
[Miller IJ, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/33000006/)
[Wilson RL, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/32000007/)
[Taylor SM, et al, (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/31000008/)
Show full description